Medium impact
Oncaspar® (pegaspargase) (Revised)
Humana·Effective Feb 1, 2026
Humana Medicaid Louisiana revised its Oncaspar (pegaspargase) coverage policy effective February 1, 2026, with updates as of July 22, 2026. This is a Prior Authorization policy for pegaspargase used in acute lymphoblastic leukemia (ALL) treatment. Coverage requires diagnosis of ALL and use as part of multi-agent chemotherapy, with specific exclusions for disease progression, prior thrombosis, pancreatitis, hemorrhagic events, or elevated bilirubin levels.